Michael Aaron Kelly, Director at NEOGENOMICS INC (NEO), bought 5,000 shares at $7.60 ($38K) on 2025-05-27, disclosed to the SEC on 2025-05-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.